Leawood, KS, United States of America

Maryline Roe

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aratana Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maryline Roe. Retrieved from https://idiyas.com/inventor/maryline-roe-mradi027

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maryline Roe - Innovator in Veterinary Ophthalmology

Introduction

Maryline Roe is a distinguished inventor based in Leawood, Kansas. She has made significant contributions to the field of veterinary medicine, particularly in the area of ophthalmology. Her innovative work focuses on developing solutions for eye infections in companion animals.

Latest Patents

Maryline Roe holds a patent for an eye drop composition. This invention comprises 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one. The eye drop composition is designed for the diagnosis and treatment of herpetic eye infections in companion animals. This patent highlights her commitment to improving animal health through innovative solutions.

Career Highlights

Maryline Roe is currently employed at Aratana Therapeutics, Inc., a company dedicated to developing innovative therapeutics for pets. Her role at the company allows her to apply her expertise in veterinary medicine and contribute to the advancement of animal healthcare.

Collaborations

Maryline has collaborated with notable coworkers, including Ainola Billiet and Erwin Blomsma. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Maryline Roe's contributions to veterinary ophthalmology through her patented eye drop composition demonstrate her dedication to enhancing the health and well-being of companion animals. Her work at Aratana Therapeutics, Inc. and collaborations with her colleagues further emphasize her impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…